G. Nar, “Is serum Fibroblast Growth Factor 21 associated with the severity or presence of coronary artery disease? FGF-21 and coronary artery disease”, J Med Biochem, vol. 41, no. 2, pp. 162–167, Sep. 2021, doi: 10.5937/jomb0-30191.